file1,
file2, etc. all in the same folder or directory;
first, locate one of the files with the [Browse...] button. Then alter the
file path in the box above to include '*' character (eg. file*).
Wildcard '?' to blanket only one character works too.| Historiographs |
Grand Totals: LCS 121, GCS 3531, CR 4288 Collection span: 1979 - 2009 | |
| Word(i) List (760) Word count: 2047, All words count: 2852 | ||
| # | Word | Recs | TLCS | TGCS |
|---|---|---|---|---|
| 201 | URETHRAL | 3 | 0 | 41 |
| 202 | FREQUENCY | 4 | 7 | 40 |
| 203 | ATTITUDES | 1 | 0 | 39 |
| 204 | CLINICAL | 7 | 1 | 39 |
| 205 | COMBINED | 3 | 1 | 39 |
| 206 | COMPLEMENTARY | 1 | 0 | 39 |
| 207 | EVALUATION | 5 | 0 | 39 |
| 208 | MEDICINE | 1 | 0 | 39 |
| 209 | DIAGNOSIS | 5 | 3 | 38 |
| 210 | IRRADIATION | 3 | 0 | 38 |
| 211 | CAUSES | 1 | 1 | 37 |
| 212 | DETERMINED | 1 | 1 | 37 |
| 213 | DISSEMINATION | 1 | 1 | 37 |
| 214 | ASSISTED | 11 | 2 | 36 |
| 215 | ASSOCIATED | 1 | 0 | 36 |
| 216 | CYTOKINE | 1 | 0 | 36 |
| 217 | DURABLE | 1 | 1 | 36 |
| 218 | HAND | 10 | 2 | 36 |
| 219 | MB49 | 1 | 0 | 36 |
| 220 | MESSENGER | 1 | 0 | 36 |
| 221 | MOUSE | 2 | 0 | 36 |
| 222 | PT3NO | 1 | 1 | 36 |
| 223 | TH1 | 1 | 0 | 36 |
| 224 | TH2 | 1 | 0 | 36 |
| 225 | REVIEW | 3 | 2 | 35 |
| 226 | BENZOPYRONE | 1 | 0 | 33 |
| 227 | BIOLOGICAL | 1 | 0 | 33 |
| 228 | BULLS | 1 | 0 | 33 |
| 229 | COUMARIN | 1 | 0 | 33 |
| 230 | DISCRIMINATORS | 1 | 0 | 33 |
| # | Word | Recs | TLCS | TGCS |
| 231 | ESCALATION | 2 | 0 | 33 |
| 232 | EYES | 1 | 0 | 33 |
| 233 | FOCALLY | 1 | 0 | 33 |
| 234 | HALOS | 1 | 0 | 33 |
| 235 | HORMONAL | 5 | 1 | 33 |
| 236 | LOCALIZED | 4 | 0 | 33 |
| 237 | METASTASES | 1 | 0 | 33 |
| 238 | OCCULT | 2 | 0 | 33 |
| 239 | OSSEOUS | 1 | 0 | 33 |
| 240 | PALLIATIVE | 1 | 0 | 33 |
| 241 | SUPPORT | 1 | 0 | 33 |
| 242 | SYMPTOMATIC | 1 | 0 | 33 |
| 243 | USEFUL | 1 | 0 | 33 |
| 244 | ACTION | 1 | 0 | 31 |
| 245 | BOTULINUM | 1 | 0 | 31 |
| 246 | CHARACTERIZATION | 2 | 0 | 31 |
| 247 | ELECTROPHYSIOLOGIC | 1 | 0 | 31 |
| 248 | IMPLICATIONS | 3 | 0 | 31 |
| 249 | OUTCOMES | 3 | 1 | 31 |
| 250 | PHARMACOLOGIC | 1 | 0 | 31 |
| 251 | SCATTER | 1 | 0 | 31 |
| 252 | TISSUES | 1 | 0 | 31 |
| 253 | TOXIN | 1 | 0 | 31 |
| 254 | TYPES | 1 | 0 | 31 |
| 255 | VITRO | 1 | 0 | 31 |
| 256 | CONTACT | 4 | 2 | 30 |
| 257 | DIRECTED | 3 | 0 | 30 |
| 258 | LASER | 4 | 2 | 30 |
| 259 | MULTIGENE | 1 | 1 | 30 |
| 260 | TECHNIQUE | 8 | 1 | 30 |
| # | Word | Recs | TLCS | TGCS |
| 261 | TRANSCRIPTION | 1 | 1 | 30 |
| 262 | CONFORMAL | 3 | 1 | 29 |
| 263 | CULTURE | 1 | 0 | 29 |
| 264 | DELAY | 2 | 1 | 29 |
| 265 | INHIBITION | 1 | 0 | 29 |
| 266 | INTERFERENCE | 1 | 0 | 29 |
| 267 | MICRO | 2 | 0 | 29 |
| 268 | SEXUAL | 2 | 1 | 29 |
| 269 | SURAMIN | 1 | 0 | 29 |
| 270 | HARMONIC | 2 | 2 | 28 |
| 271 | ASPECTS | 1 | 0 | 27 |
| 272 | BIOPSYCHOSOCIAL | 1 | 0 | 27 |
| 273 | MOUNT | 3 | 2 | 27 |
| 274 | ORPHANED | 1 | 1 | 27 |
| 275 | POXVIRUS | 1 | 1 | 27 |
| 276 | SITU | 2 | 0 | 27 |
| 277 | SONAZOID | 1 | 2 | 27 |
| 278 | UNDERAPPRECIATED | 1 | 1 | 27 |
| 279 | VECTORS | 1 | 1 | 27 |
| 280 | WHOLE | 3 | 2 | 27 |
| 281 | HERNIATION | 1 | 0 | 25 |
| 282 | ISSUES | 2 | 2 | 25 |
| 283 | NEOADJUVANT | 2 | 1 | 25 |
| 284 | PAPILLARY | 2 | 0 | 25 |
| 285 | RESULTS | 4 | 0 | 25 |
| 286 | BTA | 1 | 0 | 24 |
| 287 | KIT | 1 | 0 | 24 |
| 288 | NEPHRECTOMY | 8 | 1 | 24 |
| 289 | STAT | 1 | 0 | 24 |
| 290 | TEST | 1 | 0 | 24 |
| # | Word | Recs | TLCS | TGCS |
| 291 | UTILITY | 1 | 0 | 24 |
| 292 | MORBIDITY | 2 | 0 | 23 |
| 293 | STAGE | 5 | 1 | 22 |
| 294 | INHIBITS | 1 | 2 | 21 |
| 295 | INVITRO | 1 | 2 | 21 |
| 296 | LIGATION | 2 | 0 | 21 |
| 297 | PARTIAL | 4 | 1 | 21 |
| 298 | VARICOCELE | 2 | 0 | 21 |
| 299 | NEW | 3 | 0 | 20 |
| 300 | OPTIONS | 1 | 1 | 20 |